Back to Top Skip to main content Skip to sub-navigation

Behind the scenes, DHA supports DOJ to fight compound drug fraud

Image of several large prescription bottles filled with pills The medicine in large pills can be mixed into a solution by the pharmacist and given orally. This action is commonly called “compound drugs;” such medications mix or alter a recipe of ingredients to meet a patient’s needs. However, compound drugs are not FDA-approved. (Photo by Senior Airman Hailey Staker, 28th Bomb Wing.)

Recommended Content:

TRICARE Health Program | TRICARE Pharmacy Program | Compound Drugs | Health Literacy Month 2020

If a child needs medicine in a pill that is too large to swallow, that medication can be mixed into a solution by the pharmacist and given to the child orally. This action is commonly called “compound drugs;” such medications mix or alter a recipe of ingredients to meet a patient’s needs. While patients can be treated with compound drugs without the complications from their commercially sold counterparts, the drugs create a new potential complication: medical fraud from nefarious pharmacies and providers.

Bryan Wheeler, chief of Program and Health Law and former acting general counsel at the Defense Health Agency, has followed and fought compound drug fraud committed through the TRICARE health benefit since 2015.

“We recognized that we [TRICARE] were spending an inordinate amount of money on compound drugs,” Wheeler said, “so we had to follow the money to see where the problem was coming from.”

Compound drugs are not FDA-approved, but because DHA has an open formulary, TRICARE covers and reimburses providers for certain drug ingredients. This reimbursement helped providers looking for a cost-efficient way to cater to their patients’ needs, but without even meeting a patient, individuals looking for easy money wrote false prescriptions to get reimbursed for expensive ingredients.

“In these scams, the folks providing the ingredients make money off this, pharmacists make money off this, even the doctor that writes the prescription makes money off this,” Wheeler said. “What we saw were these networks of people recruiting patients, physicians, and pharmacies to request fake prescriptions under false pretenses. These individuals would the request prescriptions for patients who had not requested them, or request prescriptions that were not medically necessary."

DHA coordinated with the Department of Justice and the Department of Defense’s Criminal Investigative Service in prosecuting individuals and companies who have committed compound drug fraud through TRICARE. So far, the government has improved care for its beneficiaries by recovering over $606 million to TRICARE in court-ordered restitution, civil judgments, and determination of improper payments. Some offenders are currently serving jail time; program exclusion for pharmacies and individuals can range up to 20 years. DHA’s Program Integrity Division and Pharmacy Operations Division work together to observe trends and create policies to prevent future fraud.

“We have numerous controls and indicators that we look at not just for compound pharmaceuticals, but in general, that help to shed some light on areas we may want to look at more closely,” said Jennifer Dietz, head of the Program Integrity Division.

Examples include the implementation of a compound exclusion list. If a provider or pharmacy files a claim through TRICARE to be reimbursed for an ingredient that shows up on the exclusion list, the claim is paused. The provider then must verify its relationship with the patient and justify the choice of ingredients in the prescription. Only then will the reimbursement be processed.

DHA’s Program Integrity Division also compiles “spike reports” to observe trends in claims within peer groups of providers and pharmacies. DHA uses link analysis to look for spikes in ingredients or claims filed within these peer groups. Compiled data can identify other potential fraud cases, add ingredients to the compound exclusion list, and help DHA identify providers or pharmacies that show up frequently in areas that are known for compound drug fraud.

Since these new implementations, DHA has seen a severe drop in new fraudulent compound drug claims. However, since no statute of limitations exists for recovering money from compound drug fraud, the team learns about old cases regularly. These cases are forwarded to agencies like DOJ and the Defense Criminal Investigative Service for actions that include pursuing restitution fees.

“I can say without a doubt that DHA is committed to protecting not only taxpayer funds, but safeguarding benefit dollars for our military,” Dietz said. “And we’ll continue working to keep that promise.”

You also may be interested in...

TRICARE Comprehensive Autism Care Demonstration Program FY 2020

Congressional Testimony
2/21/2020

S. 2943, SASC Report for FY 2017, 114-255, Pg. 205

Recommended Content:

TRICARE Health Program

Pilot Program on Incentive Programs to Improve Health Care Provided Under the TRICARE Program

Congressional Testimony
2/18/2020

S. 1356, NDAA Conference Report for FY 2016, Joint Explanatory Statement Sec. 726

Recommended Content:

TRICARE Health Program

TRICARE Prime and TRICARE Select Out-of-Pocket Expenses for Calendar Year 2020

Policy

Memo outlining the TRICARE Prime and TRICARE Select beneficiary out-of-pocket expenses for calendar year 2020. These rates will be effective January l, 2020.

MHS Minute January 2020

Video
1/21/2020
MHS Minute January 2020

Thanks for tuning in to the *NEW* MHS Minute! Check back each month to learn about more exciting events and achievements by organizations and partners across the Military Health System!

Recommended Content:

Military Health System Transformation | TRICARE Health Program

Changes in TRICARE Plan Enrollment (July 2019)

Report
1/9/2020

To assess the impact of plan changing in TRICARE, we examined data from the first quarter of the 2019 Health Care Survey of Department of Defense Beneficiaries (HCSDB), which was fielded during open enrollment.

Recommended Content:

Health Care Survey of DoD Beneficiaries | TRICARE Health Program

Achievements in 2019 provide strong foundation for year ahead

Article
12/23/2019
A Year in Review: Year of Military Health 2019

Dedication, commitment to mission praised as changes continue

Recommended Content:

TRICARE Health Program | MHS GENESIS | Research and Innovation | Medical and Dental Preventive Care Fitness | Military Health System Transformation

New 3-D mammogram option the next step in diagnosis, treatment

Article
12/19/2019
Chief Hospital Corpsman Naomi Perez, a certified mammogram technician (left), conducts a mammogram for a patient at Naval Hospital Pensacola. A mammogram is a low-dose X-ray procedure used to detect the early stages of breast cancer. A policy change effective Jan. 1, 2020, will allow digital breast tomosynthesis, or 3-D mammography, to be used to screen for breast cancer. The procedure – known technically as Digital Breast Tomosynthesis (DBT) – will be offered primarily to women age 40 and older, and women age 30 and older who are considered high-risk for breast cancer.  The procedure’s 3-D images provide a more thorough means of detecting the disease. (U.S. Navy Photo by Mass Communication Specialist 1st Class Brannon Deugan)

Procedure would enhance effectiveness of breast cancer screening

Recommended Content:

TRICARE Health Program | Women's Health

3D Mammography Toolkit

Publication
12/19/2019

Recommended Content:

TRICARE Health Program | Women's Health

3D Mammogram Screensaver

Photo
12/17/2019
This graphic states information about 3-D Mammography

Share this screensaver to spread the word about 3-D Mammography coverage

Recommended Content:

Access to Health Care | TRICARE Health Program

3D Mammogram Facebook Post

Photo
12/17/2019
This graphic states information about 3-D Mammography

Share this graphic to spread the word about 3-D Mammography coverage

Recommended Content:

TRICARE Health Program

3D Mammography Infographic 1

Publication
12/16/2019

Share this infographic to spread the word about 3-D Mammography coverage

Recommended Content:

TRICARE Health Program | Women's Health

3D Mammography Infographic 2

Publication
12/16/2019

Share this infographic to spread the word about 3-D Mammography coverage

Recommended Content:

TRICARE Health Program | Women's Health

Talking_Points_3D_Mammography

Publication
12/16/2019

These talking points share information about 3-D mammography

Recommended Content:

TRICARE Health Program | Women's Health

TRICARE Specialty Drug Network Accessibility

Congressional Testimony
12/13/2019

H.R. 2500, HASC Report for FY 2020, 116-120, Pg. 167

Recommended Content:

TRICARE Health Program

Open Season and BWE Issue Annex

Publication
11/23/2019

This Open Season and BWE Issue Annex contains products with additional information about how to enroll during Open Season

Recommended Content:

TRICARE Health Program
<< < 1 2 3 4 5  ... > >> 
Showing results 31 - 45 Page 3 of 15

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.